Interleukin-25: A two-edged sword in the control of immune-inflammatory responses

Cytokine and Growth Factor Reviews

Volumn 21, Issue 6, 2010, Pages 471-475

  Monteleone, Giovanni ^a   Pallone, Francesco ^a   MacDonald, Thomas T ^b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Allergic diseases; Diabetes; IBD; IL 25; Multiple sclerosis; Th cells

Indexed keywords

EOTAXIN; FIBROBLAST GROWTH FACTOR; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 17 RECEPTOR; INTERLEUKIN 17 RECEPTOR BETA; INTERLEUKIN 1BETA; INTERLEUKIN 25; INTERLEUKIN 6; STAT6 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ALLERGIC ENCEPHALOMYELITIS; BASOPHIL; CELL DIFFERENTIATION; COLITIS; DIABETES MELLITUS; DOWN REGULATION; ENDOTHELIUM CELL; ENDOTOXEMIA; ENZYME ACTIVATION; EOSINOPHIL; GENETIC TRANSCRIPTION; HELPER CELL; HUMAN; IMMUNE RESPONSE; LYMPHOCYTE FUNCTION; MAST CELL; NATURAL KILLER T CELL; NONHUMAN; POLARIZATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MOTIF; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TH1 CELL;

ANIMALS; ENDOTHELIAL CELLS; IMMUNITY, INNATE; INTERLEUKIN-17; MICE; RECEPTORS, INTERLEUKIN-17; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, HELPER-INDUCER; TH2 CELLS;

EID: 78649704149     PISSN: 13596101     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cytogfr.2010.05.001     Document Type: Review

References (46)

1. Joffre O., Nolte M.A., Spörri R., Reis e Sousa C. Inflammatory signals in dendritic cell activation and the induction of adaptive immunity. Immunol Rev 2009, 227:234-247.
2. Damsker J.M., Hansen A.M., Caspi R.R. Th1 and Th17 cells: adversaries and collaborators. Ann N Y Acad Sci 2010, 1183:211-221.
3. Zhu J., Paul W.E. Heterogeneity and plasticity of T helper cells. Cell Res 2010, 20:4-12.
4. de Jong E., Suddason T., Lord G.M. Translational mini-review series on Th17 cells: development of mouse and human T helper 17 cells. Clin Exp Immunol 2010, 159:148-158.
5. Hori S., Nomura T., Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003, 299:1057-1061.
6. Eyerich S., Eyerich K., Pennino D., Carbone T., Nasorri F., Pallotta S., et al. Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling. J Clin Invest 2009, 119:3573-3585.
7. Fort M.M., Cheung J., Yen D., Li J., Zurawski S.M., Lo S., et al. IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo. Immunity 2001, 15:985-995.
8. Angkasekwinai P., Park H., Wang Y.H., Wang Y.H., Chang S.H., Corry D.B., et al. Interleukin 25 promotes the initiation of proallergic type 2 responses. J Exp Med 2007, 204:1509-1517.
9. Zaph C., Du Y., Saenz S.A., Nair M.G., Perrigoue J.G., Taylor B.C., et al. Commensal-dependent expression of IL-25 regulates the IL-23-IL-17 axis in the intestine. J Exp Med 2008, 205:2191-2198.
10. Caruso R., Sarra M., Stolfi C., Rizzo A., Fina D., Fantini M.C., et al. Interleukin-25 inhibits interleukin-12 production and Th1 cell-driven inflammation in the gut. Gastroenterology 2009, 136:2270-2279.
11. Ikeda K., Nakajima H., Suzuki K., Kagami S., Hirose K., Suto A., et al. Mast cells produce interleukin-25 upon Fc epsilon RI-mediated activation. Blood 2003, 101:3594-3596.
12. Kang C.M., Jang A.S., Ahn M.H., Shin J.A., Kim J.H., Choi Y.S., et al. Interleukin-25 and interleukin-13 production by alveolar macrophages in response to particles. Am J Respir Cell Mol Biol 2005, 33:290-296.
13. Dolgachev V., Petersen B.C., Budelsky A.L., Berlin A.A., Lukacs N.W. Pulmonary IL-17E (IL-25) production and IL-17RB+ myeloid cell-derived Th2 cytokine production are dependent upon stem cell factor-induced responses during chronic allergic pulmonary disease. J Immunol 2009, 183:5705-5715.
14. Wang Y.H., Angkasekwinai P., Lu N., Voo K.S., Arima K., Hanabuchi S., et al. IL-25 augments type 2 immune responses by enhancing the expansion and functions of TSLP-DC-activated Th2 memory cells. J Exp Med 2007, 204:1837-1847.
15. Sonobe Y., Takeuchi H., Kataoka K., Li H., Jin S., Mimuro M., et al. Interleukin-25 expressed by brain capillary endothelial cells maintains blood-brain barrier function in a protein kinase Cepsilon-dependent manner. J Biol Chem 2009, 284:31834-31842.
16. Rickel E.A., Siegel L.A., Yoon B.R., Rottman J.B., Kugler D.G., Swart D.A., et al. Identification of functional roles for both IL-17RB and IL-17RA in mediating IL-25-induced activities. J Immunol 2008, 181:4299-4310.
17. Lee J., Ho W.H., Maruoka M., Corpuz R.T., Baldwin D.T., Foster J.S., et al. IL-17E, a novel proinflammatory ligand for the IL-17 receptor homolog IL-17Rh1. J Biol Chem 2001, 276:1660-1664.
18. Caruso R., Stolfi C., Sarra M., Rizzo A., Fantini M.C., Pallone F., et al. Inhibition of monocyte-derived inflammatory cytokines by IL-25 occurs via p38 Map kinase-dependent induction of Socs-3. Blood 2009, 113:3512-3519.
19. Terashima A., Watarai H., Inoue S., Sekine E., Nakagawa R., Hase K., et al. A novel subset of mouse NKT cells bearing the IL-17 receptor B responds to IL-25 and contributes to airway hyperreactivity. J Exp Med 2008, 205:2727-2733.
20. Stock P., Lombardi V., Kohlrautz V., Akbari O. Induction of airway hyperreactivity by IL-25 is dependent on a subset of invariant NKT cells expressing IL-17RB. J Immunol 2009, 182:5116-5122.
21. Wong C.K., Cheung P.F., Ip W.K., Lam C.W. Interleukin-25-induced chemokines and interleukin-6 release from eosinophils is mediated by p38 mitogen-activated protein kinase, c-Jun N-terminal kinase, and nuclear factor-kappaB. Am J Respir Cell Mol Biol 2005, 33:186-194.
22. Maezawa Y., Nakajima H., Suzuki K., Tamachi T., Ikeda K., Inoue J., et al. Involvement of TNF receptor-associated factor 6 in IL-25 receptor signaling. J Immunol 2006, 176:1013-1018.
23. Chang S.H., Park H., Dong C. Act1 adaptor protein is an immediate and essential signaling component of interleukin-17 receptor. J Biol Chem 2006, 281:35603-35607.
24. Novatchkova M., Leibbrandt A., Werzowa J., Neubüser A., Eisenhaber F. The STIR-domain superfamily in signal transduction, development and immunity. Trends Biochem Sci 2003, 28:226-229.
25. Swaidani S., Bulek K., Kang Z., Liu C., Lu Y., Yin W., et al. The critical role of epithelial-derived Act1 in IL-17- and IL-25-mediated pulmonary inflammation. J Immunol 2009, 182:1631-1640.
26. Louten J., Boniface K., de Waal Malefyt R. Development and function of TH17 cells in health and disease. J Allergy Clin Immunol 2009, 123:1004-1011.
27. Fallon P.G., Ballantyne S.J., Mangan N.E., Barlow J.L., Dasvarma A., Hewett D.R., et al. Identification of an interleukin (IL)-25-dependent cell population that provides IL-4, IL-5, and IL-13 at the onset of helminth expulsion. J Exp Med 2006, 203:1105-1116.
28. Hurst S.D., Muchamuel T., Gorman D.M., Gilbert J.M., Clifford T., Kwan S., et al. New IL-17 family members promote Th1 or Th2 responses in the lung: in vivo function of the novel cytokine IL-25. J Immunol 2002, 169:443-453.
29. Kim M.R., Manoukian R., Yeh R., Silbiger S.M., Danilenko D.M., Scully S., et al. Transgenic overexpression of human IL-17E results in eosinophilia, B-lymphocyte hyperplasia, and altered antibody production. Blood 2002, 100:2330-2340.
30. Pan G., French D., Mao W., Maruoka M., Risser P., Lee J., et al. Forced expression of murine IL-17E induces growth retardation, jaundice, a Th2-biased response, and multiorgan inflammation in mice. J Immunol 2001, 167:6559-6567.
31. Sharkhuu T., Matthaei K.I., Forbes E., Mahalingam S., Hogan S.P., Hansbro P.M., et al. Mechanism of interleukin-25 (IL-17E)-induced pulmonary inflammation and airways hyper-reactivity. Clin Exp Allergy 2006, 36:1575-1583.
32. Shinkai K., Mohrs M., Locksley R.M. Helper T cells regulate type-2 innate immunity in vivo. Nature 2002, 420:825-829.
33. Voehringer D., Shinkai K. Locksley RM. Type 2 immunity reflects orchestrated recruitment of cells committed to IL-4 production. Immunity 2004, 20:267-277.
34. Claudio E., Sønder S.U., Saret S., Carvalho G., Ramalingam T.R., Wynn T.A., et al. The adaptor protein CIKS/Act1 is essential for IL-25-mediated allergic airway inflammation. J Immunol 2009, 182:1617-1630.
35. Saenz S.A., Siracusa M.C., Perrigoue J.G., Spencer S.P., Urban J.F., Tocker J.E., et al. IL25 elicits a multipotent progenitor cell population that promotes T(H)2 cytokine responses. Nature 2010, March 3 [Epub ahead of print].
36. Tamachi T., Maezawa Y., Ikeda K., Kagami S., Hatano M., Seto Y., et al. IL-25 enhances allergic airway inflammation by amplifying a TH2 cell-dependent pathway in mice. J Allergy Clin Immunol 2006, 118:606-614.
37. Jarnicki A.G., Fallon P.G. T helper type-2 cytokine responses: potential therapeutic targets. Curr Opin Pharmacol 2003, 3:449-455.
38. Veldhoen M., Uyttenhove C., van Snick J., Helmby H., Westendorf A., Buer J., et al. Transforming growth factor-beta 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nat Immunol 2008, 9:1341-1346.
39. Angkasekwinai P., Chang S.H., Thapa M., Watarai H., Dong C. Regulation of IL-9 expression by IL-25 signaling. Nat Immunol 2010, 11:250-256.
40. Owyang A.M., Zaph C., Wilson E.H., Guild K.J., McClanahan T., Miller H.R., et al. Interleukin 25 regulates type 2 cytokine-dependent immunity and limits chronic inflammation in the gastrointestinal tract. J Exp Med 2006, 203:843-849.
41. Kleinschek M.A., Owyang A.M., Joyce-Shaikh B., Langrish C.L., Chen Y., Gorman D.M., et al. IL-25 regulates Th17 function in autoimmune inflammation. J Exp Med 2007, 204:161-170.
42. Mchenga S.S., Wang D., Li C., Shan F., Lu C. Inhibitory effect of recombinant IL-25 on the development of dextran sulfate sodium-induced experimental colitis in mice. Cell Mol Immunol 2008, 5:425-431.
43. Emamaullee J.A., Davis J., Merani S., Toso C., Elliott J.F., Thiesen A., et al. Inhibition of Th17 cells regulates autoimmune diabetes in NOD mice. Diabetes 2009, 58:1302-1311.
44. Létuvé S., Lajoie-Kadoch S., Audusseau S., Rothenberg M.E., Fiset P.O., Ludwig M.S., et al. IL-17E upregulates the expression of proinflammatory cytokines in lung fibroblasts. J Allergy Clin Immunol 2006, 117:590-596.
45. Breese E.J., Michie C.A., Nicholls S.W., Murch S.H., Williams C.B., Domizio P., et al. Tumor necrosis factor alpha-producing cells in the intestinal mucosa of children with inflammatory bowel disease. Gastroenterology 1994, 106:1455-1466.
46. Forsberg G., Hernell O., Melgar S., Israelsson A., Hammarström S., Hammarström M.L. Paradoxical coexpression of proinflammatory and down-regulatory cytokines in intestinal T cells in childhood celiac disease. Gastroenterology 2002, 123:667-678.